Ospedale della Misericordia - Grosseto Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2004
NCT00643045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Ospedale della Misericordia, Grosseto, Italy

Active Ingredients

Drugs in Phase 4 Trials (2)

iodixanol (visipaque) (1 trial)

iopromide (ultravist) (1 trial)

Drugs in Phase 3 Trials (1)

safinamide (xadago) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3